Kristbjorg Gunnarsdottir
Overview
Explore the profile of Kristbjorg Gunnarsdottir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
1225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kristjansdottir K, Norddahl G, Ivarsdottir E, Halldorsson G, Einarsson G, Bjarnadottir K, et al.
J Allergy Clin Immunol
. 2024 Oct;
155(1):228-235.
PMID: 39423878
Background: Signal transducer and activator of transcription 6 (STAT6) is central to type 2 (T2) inflammation, and common noncoding variants at the STAT6 locus associate with various T2 inflammatory traits,...
2.
Olafsdottir T, Thorleifsson G, Lopez de Lapuente Portilla A, Jonsson S, Stefansdottir L, Niroula A, et al.
Nat Commun
. 2024 Sep;
15(1):8054.
PMID: 39277589
Immunoglobulin G (IgG) is the main isotype of antibody in human blood. IgG consists of four subclasses (IgG1 to IgG4), encoded by separate constant region genes within the Ig heavy...
3.
Saevarsdottir S, Bjarnadottir K, Markusson T, Berglund J, Olafsdottir T, Halldorsson G, et al.
Nat Commun
. 2024 Jul;
15(1):5748.
PMID: 38982041
Autoimmune thyroid disease (AITD) is a common autoimmune disease. In a GWAS meta-analysis of 110,945 cases and 1,084,290 controls, 290 sequence variants at 225 loci are associated with AITD. Of...
4.
Hjorleifsson Eldjarn G, Ferkingstad E, Lund S, Helgason H, Magnusson O, Gunnarsdottir K, et al.
Nature
. 2024 May;
630(8015):E3.
PMID: 38778117
No abstract available.
5.
Hjorleifsson Eldjarn G, Ferkingstad E, Lund S, Helgason H, Magnusson O, Gunnarsdottir K, et al.
Nature
. 2023 Oct;
622(7982):348-358.
PMID: 37794188
High-throughput proteomics platforms measuring thousands of proteins in plasma combined with genomic and phenotypic information have the power to bridge the gap between the genome and diseases. Here we performed...
6.
Magnusson M, Agnarsson B, Jonasson J, Tryggvason T, Aeffner F, le Roux L, et al.
Br J Cancer
. 2023 Aug;
129(7):1142-1151.
PMID: 37596405
Background: The TNM system is used to assess prognosis after colorectal cancer (CRC) diagnosis. Other prognostic factors reported include histopathological assessments of the tumour, tumour mutations and proteins in the...
7.
Holm H, Ivarsdottir E, Olafsdottir T, Thorolfsdottir R, Eythorsson E, Norland K, et al.
Commun Med (Lond)
. 2023 Jul;
3(1):94.
PMID: 37414856
Background: Persistent symptoms are common after SARS-CoV-2 infection but correlation with objective measures is unclear. Methods: We invited all 3098 adults who tested SARS-CoV-2 positive in Iceland before October 2020...
8.
Ajore R, Niroula A, Pertesi M, Cafaro C, Thodberg M, Went M, et al.
Nat Commun
. 2022 Dec;
13(1):7725.
PMID: 36513657
No abstract available.
9.
Norddahl G, Melsted P, Gunnarsdottir K, Halldorsson G, Olafsdottir T, Gylfason A, et al.
Nat Commun
. 2022 Sep;
13(1):5701.
PMID: 36171188
By the end of July 2021, the majority of the Icelandic population had received vaccination against COVID-19. In mid-July a wave of SARS-CoV-2 infections, dominated by the Delta variant, spread...
10.
Olafsdottir T, Bjarnadottir K, Norddahl G, Halldorsson G, Melsted P, Gunnarsdottir K, et al.
Commun Biol
. 2022 Sep;
5(1):914.
PMID: 36068292
Memory T-cell responses following SARS-CoV-2 infection have been extensively investigated but many studies have been small with a limited range of disease severity. Here we analyze SARS-CoV-2 reactive T-cell responses...